CBST Financial Facts

Other revenues: 654K
Total revenues, net: 229.93M
See Full Income Statement

Total current liabilities: 204.04M
Long-term contingent consideration: 152.28M
See Full Balance Sheet

Earnings History for Cubist Pharmaceuticals (CBST)

  |   Expand Research on CBST
Next EPS Date 7/18/13 *Est. EPS Growth Rate -24.4% *Last Qtr.
Average EPS % Beat Rate +20.8% Revenue Growth Rate +8.6% *Last Qtr.
Average % Move 1-Wk after EPS -0.1%    
Date  Qtr EPS Cons. Surprise Revs Cons. Estimize EPS/Revs Gd. % Since Details
4/18/13 Q113 $0.34$0.31 +$0.03$229.9M$243.55M N/A / N/A N/A +24.3% Details
1/23/13 Q412 $0.48$0.48 $0.00$245.9M$246.42M N/A / N/A N/A +30.9% Details
10/18/12 Q312 $0.55$0.45 +$0.10$238.2M$240.04M N/A / N/A N/A +18.2% Details
7/19/12 Q212 $0.68$0.45 +$0.23$230.6M$226.05M N/A / N/A N/A +37.5% Details
4/18/12 Q112 $0.45$0.44 +$0.01$211.7M$210.54M N/A / N/A N/A +37.5% Details
1/19/12 Q411 $0.66$0.32 +$0.34$213M$204.74M N/A / N/A N/A +38.4% Details
10/19/11 Q311 $0.85$0.31 +$0.54$201.7M$182.91M N/A / N/A N/A +52.6% Details
7/14/11 Q211 $0.59$0.41 +$0.18$176.8M$174.82M N/A / N/A N/A +56% Details
Like CBST Earnings? Also take a look at OPTR, AZN, TUMI, HSP

CBST Earnings News